Literature DB >> 23504710

BACE1 and presenilin/γ-secretase regulate proteolytic processing of KCNE1 and 2, auxiliary subunits of voltage-gated potassium channels.

Carolyn C Sachse1, Young Hye Kim, Marianne Agsten, Tobias Huth, Christian Alzheimer, Dora M Kovacs, Doo Yeon Kim.   

Abstract

BACE1 and presenilin (PS)/γ-secretase play a major role in Alzheimer's disease pathogenesis by regulating amyloid-β peptide generation. We recently showed that these secretases also regulate the processing of voltage-gated sodium channel auxiliary β-subunits and thereby modulate membrane excitability. Here, we report that KCNE1 and KCNE2, auxiliary subunits of voltage-gated potassium channels, undergo sequential cleavage mediated by either α-secretase and PS/γ-secretase or BACE1 and PS/γ-secretase in cells. Elevated α-secretase or BACE1 activities increased C-terminal fragment (CTF) levels of KCNE1 and 2 in human embryonic kidney (HEK293T) and rat neuroblastoma (B104) cells. KCNE-CTFs were then further processed by PS/γ-secretase to KCNE intracellular domains. These KCNE cleavages were specifically blocked by chemical inhibitors of the secretases in the same cell models. We also verified our results in mouse cardiomyocytes and cultured primary neurons. Endogenous KCNE1- and KCNE2-CTF levels increased by 2- to 4-fold on PS/γ-secretase inhibition or BACE1 overexpression in these cells. Furthermore, the elevated BACE1 activity increased KCNE1 processing and shifted KCNE1/KCNQ1 channel activation curve to more positive potentials in HEK cells. KCNE1/KCNQ1 channel is a cardiac potassium channel complex, and the positive shift would lead to a decrease in membrane repolarization during cardiac action potential. Together, these results clearly showed that KCNE1 and KCNE2 cleavages are regulated by BACE1 and PS/γ-secretase activities under physiological conditions. Our results also suggest a functional role of KCNE cleavage in regulating voltage-gated potassium channels.

Entities:  

Keywords:  Alzheimer's disease; KCNQ1; MiRP; MinK

Mesh:

Substances:

Year:  2013        PMID: 23504710      PMCID: PMC3659364          DOI: 10.1096/fj.12-214056

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  48 in total

1.  minK-related peptide 1 associates with Kv4.2 and modulates its gating function: potential role as beta subunit of cardiac transient outward channel?

Authors:  M Zhang; M Jiang; G N Tseng
Journal:  Circ Res       Date:  2001-05-25       Impact factor: 17.367

2.  Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease.

Authors:  Li-Bang Yang; Kristina Lindholm; Riqiang Yan; Martin Citron; Weiming Xia; Xiao-Li Yang; Thomas Beach; Lucia Sue; Philip Wong; Donald Price; Rena Li; Yong Shen
Journal:  Nat Med       Date:  2003-01       Impact factor: 53.440

3.  Up-regulation of the Kv3.4 potassium channel subunit in early stages of Alzheimer's disease.

Authors:  Ester Angulo; Véronique Noé; Vicent Casadó; Josefa Mallol; Teresa Gomez-Isla; Carmen Lluis; Isidre Ferrer; Carlos J Ciudad; Rafael Franco
Journal:  J Neurochem       Date:  2004-11       Impact factor: 5.372

4.  Regulation of the Kv2.1 potassium channel by MinK and MiRP1.

Authors:  Zoe A McCrossan; Torsten K Roepke; Anthony Lewis; Gianina Panaghie; Geoffrey W Abbott
Journal:  J Membr Biol       Date:  2009-02-14       Impact factor: 1.843

5.  Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel.

Authors:  M C Sanguinetti; M E Curran; A Zou; J Shen; P S Spector; D L Atkinson; M T Keating
Journal:  Nature       Date:  1996-11-07       Impact factor: 49.962

6.  BACE1 deficiency causes altered neuronal activity and neurodegeneration.

Authors:  Xiangyou Hu; Xiangdong Zhou; Wanxia He; Jun Yang; Wencheng Xiong; Philip Wong; Christopher G Wilson; Riqiang Yan
Journal:  J Neurosci       Date:  2010-06-30       Impact factor: 6.167

Review 7.  Alzheimer's secretases regulate voltage-gated sodium channels.

Authors:  Dora M Kovacs; Manuel T Gersbacher; Doo Yeon Kim
Journal:  Neurosci Lett       Date:  2010-09-15       Impact factor: 3.046

8.  Reduced sodium channel Na(v)1.1 levels in BACE1-null mice.

Authors:  Doo Yeon Kim; Manuel T Gersbacher; Perrine Inquimbert; Dora M Kovacs
Journal:  J Biol Chem       Date:  2010-12-29       Impact factor: 5.157

9.  Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model.

Authors:  Laure Verret; Edward O Mann; Giao B Hang; Albert M I Barth; Inma Cobos; Kaitlyn Ho; Nino Devidze; Eliezer Masliah; Anatol C Kreitzer; Istvan Mody; Lennart Mucke; Jorge J Palop
Journal:  Cell       Date:  2012-04-27       Impact factor: 41.582

Review 10.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

View more
  24 in total

Review 1.  From Molecular Circuit Dysfunction to Disease: Case Studies in Epilepsy, Traumatic Brain Injury, and Alzheimer's Disease.

Authors:  Chris G Dulla; Douglas A Coulter; Jokubas Ziburkus
Journal:  Neuroscientist       Date:  2015-05-06       Impact factor: 7.519

Review 2.  RIP at the Synapse and the Role of Intracellular Domains in Neurons.

Authors:  Yan Jun Lee; Toh Hean Ch'ng
Journal:  Neuromolecular Med       Date:  2019-07-25       Impact factor: 3.843

Review 3.  A Close Look at BACE1 Inhibitors for Alzheimer's Disease Treatment.

Authors:  Brati Das; Riqiang Yan
Journal:  CNS Drugs       Date:  2019-03       Impact factor: 5.749

Review 4.  Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer's disease.

Authors:  Riqiang Yan; Qingyuan Fan; John Zhou; Robert Vassar
Journal:  Neurosci Biobehav Rev       Date:  2016-04-01       Impact factor: 8.989

5.  Axonal and Schwann cell BACE1 is equally required for remyelination of peripheral nerves.

Authors:  Xiangyou Hu; Jinxuan Hu; Lu Dai; Bruce Trapp; Riqiang Yan
Journal:  J Neurosci       Date:  2015-03-04       Impact factor: 6.167

Review 6.  Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling.

Authors:  Xiangyou Hu; Qingyuan Fan; Hailong Hou; Riqiang Yan
Journal:  J Neurochem       Date:  2015-11-13       Impact factor: 5.372

7.  β-Secretase BACE1 Promotes Surface Expression and Function of Kv3.4 at Hippocampal Mossy Fiber Synapses.

Authors:  Stephanie Hartmann; Fang Zheng; Michele C Kyncl; Sandra Karch; Kerstin Voelkl; Benedikt Zott; Carla D'Avanzo; Selene Lomoio; Giuseppina Tesco; Doo Y Kim; Christian Alzheimer; Tobias Huth
Journal:  J Neurosci       Date:  2018-03-05       Impact factor: 6.167

8.  Chronic Cerebral Hypoperfusion Promotes Amyloid-Beta Pathogenesis via Activating β/γ-Secretases.

Authors:  Zhiyou Cai; Zhou Liu; Ming Xiao; Chuanling Wang; Fuming Tian
Journal:  Neurochem Res       Date:  2017-08-24       Impact factor: 3.996

Review 9.  Ion channel regulation by β-secretase BACE1 - enzymatic and non-enzymatic effects beyond Alzheimer's disease.

Authors:  Sandra Lehnert; Stephanie Hartmann; Sabine Hessler; Helmuth Adelsberger; Tobias Huth; Christian Alzheimer
Journal:  Channels (Austin)       Date:  2016-06-02       Impact factor: 2.581

10.  Genetic suppression of transgenic APP rescues Hypersynchronous network activity in a mouse model of Alzeimer's disease.

Authors:  Heather A Born; Ji-Yoen Kim; Ricky R Savjani; Pritam Das; Yuri A Dabaghian; Qinxi Guo; Jong W Yoo; Dorothy R Schuler; John R Cirrito; Hui Zheng; Todd E Golde; Jeffrey L Noebels; Joanna L Jankowsky
Journal:  J Neurosci       Date:  2014-03-12       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.